This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Responses to this request are due by this Thursday, February 2, 2023. Patent owners, especially small businesses and independent inventors, need two things of the patent system: 1) Reliability/believability. We need patents that are respected when they are issued. We do not want any doubt about their validity.
Image from here On August 23, the Draft Patent (Amendment) Rules, 2023 , were published in the Gazette of India, inviting public comments by September 22. Since then, the Rules have been extensively discussed within the IP community, especially the potential impact they may have on the patent opposition mechanism.
Discussing the background of the case in this guest post, Suriya Balakanthan, highlights how these procedural lapses took place and highlights the impact that this case can have on the patentprosecution setup. Suriya is a Patent Analyst from Salem Tamil Nadu. Thereafter, a pre-grant opposition was filed on 09/01/2023 by Mr. T.
by Dennis Crouch Impact of Sonos on PatentProsecution : The recent Sonos v. Google decision threatens to grind to a halt, or at least significantly restrict, a once-common patentprosecution strategy – keeping continuation applications pending for years to obtain new claims that cover marketplace developments.
The cover article of the May 2024 edition of the CIPA Journal proposed a new test for inventive step using AI. The CIPA journal article proposes to use an AI derived measurement of semantic similarity between the claims and the prior art as a new test for inventive step. features, images, text) are represented as vectors and compared.
OpenAI is pursuing speedy patent grant Fascinatingly, OpenAI is pursuing highly accelerated grant of its IP. A patent can only be enforced once it is granted. However, it can take 3 to 5 years of patentprosecution before national patent offices to achieve grant of a patent.
We invite you to participate in the tryouts for the 2022-2023 National Patent Application Drafting Competition ! The winner of each regional round will compete in the National Finals held at the United States Patent and Trademark Office (USPTO) headquarters in Alexandria, Virginia. .
2023 ) Just in time for my early August floating trip down in the Ozarks, the Federal Circuit has affirmed the USPTO’s rejections of Float’N’Grill’s proposed reissue claims. The problem: the reissue claims omit an “essential element” of the original invention in violation of 35 U.S.C. 668 (1942).
Establishing a prima facie case of obviousness based on a multiple prior art references generally requires that the references teach or suggest all claim elements and that one of ordinary skill in the art would be motivated to combine the references to achieve the invention as claimed.
(October 5-November 23) Following a favorable outcome of preparing students and professionals for the patent agent exam and providing them with a comprehensive guide on Patents in 2022 and 2023. The IP Press presents the third cohort of the Comprehensive Course on Patents.
This fee reduction is part of an effort to reduce financial burdens and resulting barriers that discourage or prevent these entities from participating in the patent system. Most of these fee reductions have an effective date of March 22, 2023, with the remaining ones effective as of April 1, 2023.
PatentProsecution refers to the process whereby an applicant files an application before the Patent Office for the grant of a patent. This process necessarily consists of several steps to ensure that only ‘patentable’ inventions are granted protection.
2023) This case is still pending before the Federal Circuit, but I found it interesting enough for a preview. United Cannabis holds a broad marijuana patent – US9730911 – with claims directed to a liquid cannabinoid having 95% of either THC or CBD. United Cannabis Corporation v. Pure Hemp Collective Inc. 22-01363 (Fed.
by Dennis Crouch One of the more shocking patent decisions of 2023 was Judge Alsup’s holding in Sonos, Inc. C 20-06754 WHA, 2023 WL 6542320 (N.D. The scathing opinion left two Sonos multi-zone smart-speaker patents unenforceable due to prosecution laches and a rejection of the $32 million jury verdict.
Image from here In a significant development, the Delhi High Court on July 24, 2023 passed a detailed order on ‘product-by-process’ patent claims in Vifor International Ltd. As a part of the patent bargain, an inventor must describe the invention and disclose the best method to perform it. MSN Laboratories Pvt.
Draft version The requirement to amend the description of a European patent application in line with the scope of the claims is a peculiarity of European patentprosecution. Perhaps this will persuade the EPO to rethink their approach in time for 2023? emphasis added).
Feb 1, 2023, is the new deadline for providing comments to the USPTO on this RFC. Identify any specific sources of prior art not currently available through the Patents End-to-End Search system that you believe examiners should be searching. adopt a unity of invention requirement in place of the restriction requirement?
That is to say, ‘applicants’ are interested stakeholders here, and focusing on issues faced by applicants alone, just one of the many stakeholders, does not equate to understanding the patent oppositions mechanism as a whole. Assistant Controller of Patents on 12/Jan/2023 (after the release of the Monograph).
Vanda Pharmaceuticals recently filed a petition for writ of certiorari , asking the Supreme Court to review a May 2023 decision by the Federal Circuit that invalidated claims from four Vanda patents covering methods of treating Non-24-Hour Sleep-Wake Disorder (“Non-24”) using the drug tasimelteon (Hetlioz).
This fee reduction is part of an effort to reduce financial burdens and resulting barriers that discourage or prevent these entities from participating in the patent system. Most of these fee reductions have an effective date of March 22, 2023, with the remaining ones effective as of April 1, 2023. had a gross income.
Where the impugned order from the patent office (dated March 18, 2021) ran for 12 pages, the grant order (dated March 05. 2023) resolves the controversy merely in 5 lines. The impugned order also failed to consider the patent granted to the subject invention in different jurisdiction.
The international filing date of the patent application for EO is May 21, 2003 and the proprietary right over EO was granted to GlaxoSmithKline LLC in 2009. Therefore, the patent will remain active till May 21, 2023, by the virtue of Section 53 (1) of the Patent Act. The EO patent bears the number IN 233161 (IN 161).
DHC Rejects Natco’s Request to Vacate Ceritinib Interim Injunction In a detailed order passed on January 9, 2023, the Delhi High Court had granted an interim injunction to Novartis against Natco, restricting the latter from manufacturing and selling its generic version of Ceritinib, a drug used in treating lung cancer.
6, 2023) [ decision ] The Federal Circuit’s bread-and-butter over the years has been claim constructions that often surprise or confuse district court judges. But the prosecution history did not compare pH 13 with values in between 12 and 13. by Dennis Crouch Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc.,
Delhi High Court Comes Down Heavily on the Patent Office for Delay in Passing the Order Image by Freepik DHC comes down on the Patent Office for a four-year delay in issuing an order. Read this post by SpicyIP intern Jyotpreet on what this means for the delays in patentprosecution timelines. M/S Loreal S.A
In a recent order passed on August 3, 2023, the Delhi HC in Ravi Manchanda v. The Need for Transparency: The patentprosecution procedure is one that is intricate and drawn out, requiring several rounds of back-and-forth filings and clarifications. Thus, they hold immeasurable public value.
The United States Patent and Trademark Office (USPTO) yesterday republished its Request for Comments (RFC) on the establishment of an additional USPTO Regional Office in the southeast region and four new community outreach offices.
The United States Patent and Trademark Office (USPTO) yesterday republished its Request for Comments (RFC) on the establishment of an additional USPTO Regional Office in the southeast region and four new community outreach offices.
The United States Patent and Trademark Office (USPTO) yesterday republished its Request for Comments (RFC) on the establishment of an additional USPTO Regional Office in the southeast region and four new community outreach offices.
The United States Patent and Trademark Office (USPTO) yesterday republished its Request for Comments (RFC) on the establishment of an additional USPTO Regional Office in the southeast region and four new community outreach offices.
Global Partnership on AI (GPAI) The recent joint statement (June 2023) from India and the United States mentions that both countries have committed to develop joint as well as international collaboration on AI. The GPAI Summit 2023 is scheduled to be held in December in New Delhi.
The Federal Circuit recently upheld the Patent Office’s decision to reject claims in four separate reexamination cases due to obviousness-type double patenting (ODP). Unless overturned, this decision will significantly affect patent families that have patents with different expiration dates. Natco Pharma Ltd. ,
In my view, the proposed fee increases for continuation applications, RCEs, and excess claims suggest the USPTO is using financial incentives to shape applicant behavior and encourage more compact and focused patentprosecution. This aims to deter competition barriers from multiple patents on obvious variants of an invention.
Senators: Terminal disclaimers, allowed under 37 CFR 1.321(d), allow applicants to receive patents that are obvious variations of each other as long as the expiration dates match. Currently, patents tied together with a terminal disclaimer after an obviousness-type double patent rejection must be separately challenged on validity grounds.
Lava gave a mammoth 476 page judgement while dealing with issues related to novelty, inventive step, Section 3(k) and FRAND. Maharaja decision of 2023 (which the Court relied on in the present case to justify the damages) that damages are to be calculated on reasonable/ fair basis. The judgement was passed by Justice Rajbir Sehrawat.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content